202452
Poly(ethylene glycol)
average MV 8,000, hydroxyl
Manufacturer: Sigma Aldrich
CAS Number: 25322-68-3
Synonym(S): Polyethylene glycol, PEG
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 250 G | 202452-250-G | In Stock | ₹ 3,363.30 |
| 500 G | 202452-500-G | In Stock | ₹ 4,118.10 |
202452 - 250 G
In Stock
Quantity
1
Base Price: ₹ 3,363.30
GST (18%): ₹ 605.394
Total Price: ₹ 3,968.694
product name
Poly(ethylene glycol), average Mv ~8,000, powder (crystalline)
form
powder (crystalline)
Quality Level
200
mol wt
average Mv ~8,000
viscosity
800 cSt(210 °F)(lit.)
mp
60-63 °C (lit.)
density
1.27 g/mL at 25 °C
Ω-end
hydroxyl
α-end
hydroxyl
SMILES string
C(CO)O
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | RIGAKU REAGENTS PEG 1000, 50%(w/v), 100 ml, CAS# 25322-68-3 | -- | ₹ 7,803.07 | |
| | Electron Microscopy Sciences Carbowax Polyethylene Glycol, PEG 400 viscous liquid, 25322-68-3, 450ml | -- | ₹ 4,072.66 | |
| | RIGAKU REAGENTS PEG 4000, 50%(w/v), 250 ml, CAS # 25322-68-3 | -- | ₹ 13,347.36 | |
| | RIGAKU REAGENTS PEG 6000, 50%(w/v), 250 ml, CAS# 25322-68-3 | -- | ₹ 13,347.36 | |
| | Medchemexpress LLC HY-Y0873 50mL , PEG300 CAS:25322-68-3 Purity:>98% | -- | ₹ 4,491.90 | |
| | eMolecules PEG4000 | 25322-68-3 | MFCD00002882 | 100g | -- | ₹ 6,297.22 | |
| | Poly(ethylene glycol) for GPC 108,000, MilliporeSigma™ Supelco™ | -- | ₹ 1,00,361.88 | |
| | Poly(ethylene glycol) for GPC 12,000, MilliporeSigma™ Supelco™ | -- | ₹ 23,785.68 | |
| | Poly(ethylene glycol) for GPC 20,000, MilliporeSigma™ Supelco™ | -- | ₹ 23,914.02 | |
| | Poly(ethylene glycol) for GPC 200, MilliporeSigma™ Supelco™ | -- | ₹ 24,598.50 |
...
Related Products
Description
- Application: PEG in Targeted Drug Delivery: Investigating the effects of PEGylation on the surface properties of nanoparticles, which plays a crucial role in targeted drug delivery systems (Shi et al., 2021). PEG′s Role in Nanomedicine: Discussing the immunological properties of PEG and exploring its popular role in nanomedicine formulations, with a focus on immunogenic responses (Shi et al., 2022).
SAFETY INFORMATION
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves